As shown in Table 2, a higher BLC/TNFRII ratio was related to a 35‐fold elevated risk of subcentimetre adenocarcinoma compared with that in the group with a lower BLC/TNFRII ratio. This evidence concerns the gene TNFRSF1B and adenocarcinoma.